Form 8-K - Current report:
SEC Accession No. 0001193125-25-167131
Filing Date
2025-07-29
Accepted
2025-07-29 07:01:46
Documents
15
Period of Report
2025-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943437d8k.htm   iXBRL 8-K 26490
2 EX-99.1 d943437dex991.htm EX-99.1 22223
6 GRAPHIC g943437dsp005.jpg GRAPHIC 4164
7 GRAPHIC g943437dsp005a.jpg GRAPHIC 3153
  Complete submission text file 0001193125-25-167131.txt   182574

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250729.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250729_lab.xml EX-101.LAB 17912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250729_pre.xml EX-101.PRE 11230
17 EXTRACTED XBRL INSTANCE DOCUMENT d943437d8k_htm.xml XML 3710
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 251157497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)